Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,790 | 177 | 99.8% |
| Education | $5.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $652.95 | 53 | $0 (2024) |
| Novo Nordisk Inc | $526.49 | 33 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $367.34 | 19 | $0 (2023) |
| Amgen Inc. | $324.92 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $218.71 | 10 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $95.88 | 6 | $0 (2020) |
| PFIZER INC. | $87.81 | 2 | $0 (2024) |
| Antares Pharma, Inc. | $85.26 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $67.10 | 5 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $60.57 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $256.59 | 13 | Lilly USA, LLC ($70.55) |
| 2023 | $416.30 | 22 | Bayer Healthcare Pharmaceuticals Inc. ($145.29) |
| 2022 | $317.67 | 16 | Bayer HealthCare Pharmaceuticals Inc. ($160.78) |
| 2021 | $274.43 | 19 | Lilly USA, LLC ($131.48) |
| 2020 | $193.21 | 15 | Novo Nordisk Inc ($67.00) |
| 2019 | $175.95 | 13 | Novartis Pharmaceuticals Corporation ($52.95) |
| 2018 | $294.63 | 24 | Lilly USA, LLC ($109.93) |
| 2017 | $866.49 | 56 | Amgen Inc. ($213.99) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: UROLOGY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Diabetes Care | ||||||
| 06/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: DIABETES | ||||||
| 01/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardiology | ||||||
| 12/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: DIABETES | ||||||
| 12/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Biological | ||||||
| 11/28/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Diabetes | ||||||
| 11/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Cardiology | ||||||
| 10/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Diabetes | ||||||
| 10/30/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Diabetes | ||||||
| 10/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Cardio-renal | ||||||
| 10/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: Cardio-renal | ||||||
| 08/29/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes | ||||||
| 08/15/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Cardio-renal | ||||||
| 07/06/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Cardio-renal | ||||||
| 05/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,469 | 3,244 | $424,607 | $148,417 |
| 2022 | 20 | 1,342 | 2,887 | $395,460 | $143,658 |
| 2021 | 15 | 981 | 1,971 | $234,965 | $86,261 |
| 2020 | 14 | 779 | 1,465 | $187,507 | $54,878 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 342 | 998 | $199,600 | $77,613 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 127 | 231 | $64,680 | $25,949 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 182 | 367 | $55,090 | $19,640 | 35.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 374 | 778 | $38,900 | $6,535 | 16.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 23 | 209 | $9,392 | $3,491 | 37.2% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 17 | 28 | $7,129 | $2,507 | 35.2% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 12 | 16 | $5,669 | $2,277 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,800 | $1,789 | 37.3% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 19 | 32 | $5,367 | $1,226 | 22.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 18 | 26 | $3,320 | $1,138 | 34.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 20 | $3,020 | $972.17 | 32.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 69 | 101 | $5,050 | $959.30 | 19.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 45 | 49 | $4,410 | $901.30 | 20.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $4,000 | $874.78 | 21.9% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 13 | 24 | $2,596 | $720.51 | 27.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 14 | 16 | $1,568 | $567.40 | 36.2% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 16 | 17 | $1,251 | $412.88 | 33.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 41 | $4,100 | $406.20 | 9.9% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 11 | 11 | $550.00 | $272.58 | 49.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 17 | 20 | $500.00 | $105.45 | 21.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 22 | 74 | $740.00 | $26.08 | 3.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 27 | $1,350 | $23.21 | 1.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 47 | 127 | $1,524 | $10.27 | 0.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 305 | 827 | $165,400 | $69,700 | 42.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 122 | 222 | $62,160 | $27,471 | 44.2% |
About Dr. Jimmy Dailey, MD
Dr. Jimmy Dailey, MD is a Family Medicine healthcare provider based in Canton, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073598199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jimmy Dailey, MD has received a total of $2,795 in payments from pharmaceutical and medical device companies, with $256.59 received in 2024. These payments were reported across 178 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,790).
As a Medicare-enrolled provider, Dailey has provided services to 4,571 Medicare beneficiaries, totaling 9,567 services with total Medicare billing of $433,214. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Canton, TX
- Active Since 12/13/2005
- Last Updated 07/01/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073598199
Products in Payments
- TRULICITY (Drug) $446.85
- Kerendia (Drug) $367.34
- Ozempic (Drug) $243.66
- Corlanor (Drug) $232.26
- BEVESPI AEROSPHERE (Drug) $126.17
- MOUNJARO (Drug) $120.80
- Victoza (Drug) $104.68
- FARXIGA (Drug) $92.54
- NOCDURNA (Drug) $85.26
- Tresiba (Drug) $80.20
- Rybelsus (Drug) $75.30
- ELIQUIS (Drug) $68.91
- ENTRESTO (Drug) $67.10
- Repatha (Biological) $56.14
- BASAGLAR (Drug) $49.09
- MULTAQ (Drug) $48.48
- Trintellix (Drug) $37.84
- TRADJENTA (Drug) $36.21
- JARDIANCE (Drug) $31.67
- PRALUENT (Drug) $31.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Canton
Diana Brewster, Do, DO
Family Medicine — Payments: $19,624
Dr. Benjamin Swisher, M.d, M.D
Family Medicine — Payments: $17,371
Amy Hubert, M.d, M.D
Family Medicine — Payments: $15,764
Dr. Tammy Eisentrout, D.o, D.O
Family Medicine — Payments: $12,104
Jeffrey Stone, Md, MD
Family Medicine — Payments: $11,005
Kerwin Joel Lupisan, Md, MD
Family Medicine — Payments: $10,871